Options
Ease of use and comfort of a novel sensor insertion device for continuous glucose monitoring.
Ramstetter, E.; Grziwa, B.; Krichbaum, Michael; u. a. (2015): Ease of use and comfort of a novel sensor insertion device for continuous glucose monitoring., in: Diabetes Technology & Therapeutics, Larchmont, NY, USA: Liebert, Jg. 17, Nr. Supplement 1, S. A87–A88, doi: 10.1089/dia.2015.1525.
Faculty/Chair:
Author:
Title of the Journal:
Diabetes Technology & Therapeutics
ISSN:
1557-8593
1520-9156
Publisher Information:
Year of publication:
2015
Volume:
17
Issue:
Supplement 1
Pages:
Language:
English
Abstract:
Background: In continuous glucose monitoring (CGM) the accurate positioning of the sensor in the subcutaneous tissue is a prerequisite for adequate sensor performance. In this study a novel insertion device was investigated with regard to success and reliability of sensor insertion, ease-of-use of the device and discomfort associated with the insertion procedure.
Methods: 50 people with diabetes inserted themselves two sensors, one at the abdomen and a second at the hip/buttock. To determine the insertion length, a sensor with a special scaling was used. The study was approved by the Institutional Review Board and subjects had signed written informed consent.
Results: The sensors were inserted successfully with an insertion length ≥8 mm leading to a success rate of sensor insertion of 100%. Pain upon sensor insertion was reported to be low (77.5%) or moderate (18.3%). In comparison to any of the compared measures in diabetes treatment, the discomfort associated with insertion was reported to be equal or less than finger pricking (79.6%), insulin injection (77.6%) and applying other CGM systems (83.3%). Regarding the handling of the insertion device, 80% of the subjects assessed it very easy to use, and 98% rated the operating steps easy to understand.
Conclusion: The novel CGM sensor insertion device can provide people with diabetes a reliable and easy to perform procedure for safe and successful sensor insertion with a minimum of discomfort, also when compared to other CGM devices and in comparison to other measures in diabetes treatment like insulin administration or finger pricking.
Methods: 50 people with diabetes inserted themselves two sensors, one at the abdomen and a second at the hip/buttock. To determine the insertion length, a sensor with a special scaling was used. The study was approved by the Institutional Review Board and subjects had signed written informed consent.
Results: The sensors were inserted successfully with an insertion length ≥8 mm leading to a success rate of sensor insertion of 100%. Pain upon sensor insertion was reported to be low (77.5%) or moderate (18.3%). In comparison to any of the compared measures in diabetes treatment, the discomfort associated with insertion was reported to be equal or less than finger pricking (79.6%), insulin injection (77.6%) and applying other CGM systems (83.3%). Regarding the handling of the insertion device, 80% of the subjects assessed it very easy to use, and 98% rated the operating steps easy to understand.
Conclusion: The novel CGM sensor insertion device can provide people with diabetes a reliable and easy to perform procedure for safe and successful sensor insertion with a minimum of discomfort, also when compared to other CGM devices and in comparison to other measures in diabetes treatment like insulin administration or finger pricking.
Keywords:
glucose monitoring
Peer Reviewed:
Yes:
International Distribution:
Yes:
Type:
Article
Activation date:
September 15, 2022
Versioning
Question on publication
Permalink
https://fis.uni-bamberg.de/handle/uniba/55583